In contrast, CXCL10 candidate genes were mainly enriched in pathways including prostate cancer, AGE-RAGE signaling pathway in diabetic complications, Chagas disease, HIF-1 signaling pathway, hepatitis B, fluid shear stress and atherosclerosis, Kaposi sarcoma-associated herpesvirus infection, pancreatic cancer, lipid and atherosclerosis, and human T-cell leukemia virus type 1 infection (Figure 5B). This evidence concerns the gene CXCL10 and Familial prostate cancer.